Association between insomnia phenotypes and subclinical myocardial injury: the Multi-Ethnic Study of Atherosclerosis.

"Disclosure Statement FDS was funded by a PhD fellowship from the South-Eastern Norway Regional Health Authority. SMB reports personal fees from Merck, Sharpe, and Dohme, Eisai, Inc., and has received grant funding through her institute from ApniMed unrelated to the present work. CdF has received funding from the National Center for Advancing Translational Science of the National Institutes of Health Award UL1TR003015; R01HL154768, R21AG072095, and receives research funding from Abbott Diagnostics, Roche Diagnostics, Siemens Healthineers, and Ortho Diagnostics; and consults for FujiRebio, Quidel, Roche Diagnostics, Siemens Healthineers, and Ortho Diagnostics. SR was funded by grant R35HL135818 from the National Heart, Lung, and Blood Institute and reports personal fees from Apnimed Inc, Jazz Pharma, and Eli Lilly, unrelated to the present work. TO has received consultant and/or speaker honoraria from Abbott Diagnostics, Bayer, Roche Diagnostics, Novartis, and CardiNor and has received research support from AstraZeneca, Abbott Diagnostics, Roche Diagnostics, and SomaLogic through Akershus University Hospital."

"Funding This research was supported by contracts 75N92020D00001, HHSN268201500003I, N01-HC-95159, 75N92020D00005, N01-HC-95160, 75N92020D00002, N01-HC-95161, 75N92020D00003, N01-HC-95162, 75N92020D00006, N01-HC-95163, 75N92020D00004, N01-HC-95164, 75N92020D00007, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, and N01-HC-95169 from the National Heart, Lung, and Blood Institute, and by grants UL1-TR-000040, UL1-TR-001079, and UL1-TR-001420 from the National Center for Advancing Translational Sciences (NCATS). The MESA Sleep studies were supported by NHLBI HL56984 and NIA R01AG070867."